MNCs bullish on Chinese lab automation sector

Multinational corporations are accelerating their pace of bringing advanced laboratory automation to China to tap into the country's surging testing demand and enjoy the country's favorable policies in stabilizing foreign investment.

By shifting from manual to automated operations, laboratory automation reduces preanalysis faults, improves the level of biological safety protection, increases test efficiency, reduces labor costs and improves laboratory management competence.

United States-based healthcare company Abbott announced that its laboratory automation solution－the GLP system－will be launched in China by the end of this month.